Glenmark

Buy these stocks in November and sell in December

Seasonality suggests November softness and December strength, yet select Pharma counters consistently outperform. Three stocks offering the favourable risk-reward from…

November 11, 2025 05:30 IST

ICICI Lombard Dividend 2025: Check record date, eligibility, and other key details

Dividend stocks: Glenmark Pharma only stock to trade ex-dividend this week

Dividend stocks this week, September 28: Glenmark Pharma trades ex-dividend on Oct 3; watch for interim Rs 2.5 payout. Check…

September 28, 2025 07:00 IST

Nomura on Glenmark Pharma today, September 25

More pain ahead for Glenmark Pharma? 3 reasons why Nomura sees 25% downside after licencing deal for cancer drug

Discover why Nomura predicts a 25% downside for Glenmark Pharma despite its new cancer drug deal—read their analysis before investing!

September 25, 2025 10:54 IST

AbbVie signs $700 million deal with IGI Therapeutics to co-develop new multiple myeloma drug ISB 2001

Big news: AbbVie inks $700 million pact with Glenmark arm to develop and sell new cancer drug

AbbVie has entered into a $700 million licensing agreement with IGI Therapeutics to co-develop ISB 2001, a promising trispecific T-cell…

July 11, 2025 11:05 IST

Stocks making biggest moves midday: Sugar stocks, RVNL, Mobikwik and more

Stocks making the biggest moves mid-day: Bharat Dynamics, Sagility, Glenmark & more

See which stocks are moving today, including Bharat Dynamics, Sagility, Glenmark, and more; track their market action now!

July 10, 2025 14:36 IST

stocks to watch, stock in news, stocks in news, stocks to know

Stocks to watch today: From Ashok Leyland, NTPC to Paras Defence – Here’s a list of 10 stocks in focus today

Watch top stocks today: Ashok Leyland’s bonus issue, Paras Defence’s partnership, NTPC’s profit rise, and more. Stay updated!

May 26, 2025 06:40 IST

nirma, glenmark life sciences, glenmark-nirma deal, industry

Nirma Rs 1,343 crore open offer to buy more stake in Glenmark Life Sciences to start on Feb 15

The development follows Nirma’s deal to acquire 75 per cent stake in Glenmark Life Sciences for Rs 5,651.5 crore agreed…

February 9, 2024 18:57 IST

Glenmark Pharmaceuticals, Anti-Diabetic drug, Liraglutide, Glenmark news, healthcare news, pharma news,

Nirma gets CCI for acquisition of majority stake in Glenmark Life Sciences

Glenmark Life Sciences Ltd (GLS) is engaged in the business of development, manufacturing and sale of Active Pharmaceutical Ingredients (APIs).

December 19, 2023 21:12 IST

Udaan, costs, IPO, Reliance Industries, financial performance, startups, profitability, compliance, jobs, quicker deliveries, inventory

Glenmark Life Sciences posts Q2 profit rise on API boost

The Mumbai-based drugmaker said its profit rose to 1.19 billion rupees ($14.3 million) for the quarter ended Sept. 30, from…

October 20, 2023 14:46 IST

Expect gains from the Nirma deal on our books from FY25 & fruits from innovation play from FY27: Glenn Saldanha

“What this transaction does is that it helps both the companies achieve their long-term strategic goal in the best way…

September 22, 2023 15:41 IST

Glenmark, Glenmark pharmaceuticals, diabetes, blood sugar, healthcare news, pharma news,

Glenmark Pharma gets sANDA approval for its immunosuppressive drug

According to IQVIATM sales data for the 12‐month period ending June 2023, the Protopic Ointment, 0.03% market2 achieved annual sales…

August 18, 2023 09:00 IST

Pharmaceutical sector, Indian pharmaceutical sector, India colombo relations, health news, pharma news,

Glenmark USA continues to expand its Over-The-Counter Portfolio with acquisition of new drugs from Wockhardt Limited

Currently, Glenmark’s portfolio consists of 175 products authorized for distribution in the U.S. marketplace and 48 ANDAs pending approval with…

June 28, 2022 14:02 IST

Glenmark receives DCGI approval for conducting Phase 1 Clinical Trial of GRC 54276 in oncology patients

Phase 1 clinical trial is aimed at determining preliminary anti-tumor activity of its novel molecule in patients with advanced solid…

April 11, 2022 12:33 IST

Glenmark raises industry’s first sustainability-linked loan of USD 228 million

Bank of America, the sole underwriter of the entire loan, has extended USD 50 million, and Cincinnati, Ohio-based Fifth Third…

March 22, 2022 17:26 IST

Glenmark Life Sciences IPO, Glenmark Pharma

Glenmark Life Sciences IPO opens July 27, IPO size reduced; plans to sell now 63 lakh shares via OFS

Glenmark Life Sciences’, a subsidiary of Glenmark Pharmaceuticals, IPO will open for subscription next week on 27 July and close…

July 20, 2021 14:30 IST

Glenmark Q4 net profit up 6 pc at Rs 233.87 cr

The company has in place strategic levers to grow its businesses sustainably, with a focus on strengthening its balance sheet,…

May 29, 2021 13:50 IST

Glenmark launches offer to raise up to $200 million

Glenmark Pharmaceuticals today launched an offer on the Singapore Stock Exchange to raise up to USD 200 million (over Rs…

May 31, 2016 18:43 IST

Glenmark launches ‘Digihaler’ for asthma and COPD medication

The next-gen digital inhaler provides accurate digital dose counter along with low dose warning indicator to track patience adherence Glenmark…

May 25, 2016 16:35 IST

Related News

Indian Govt urges vehicle owners, DL holders to update mobile number on Vahan, Sarathi portals: Here’s how

According to Legg, the disruption will be uneven across industries.

AI will end work-from-home, says Google DeepMind Co-Founder Shane Legg

Delhi makes two key GRAP-4 rules permanent to combat ‘severe’ pollution – All you need to know

World’s richest countries in 2025: US, Singapore, Qatar, and more

hindustan copper pnb vedanta sigachi midday stock movers

4 ‘Buy’ recommendations by Motilal Oswal, with up to 52% upside potential

RBI 2025 playbook – easier banking

Business32 min ago

In 2025, the RBI implemented changes to its regulatory approach, simplifying guidelines and focusing on governance. These changes reduced costs for banks and maintained financial stability. With a new governor, the RBI aimed to boost growth by streamlining regulations and consolidating over 8,000 regulations.

View all shorts